Navigation Links
Hologic Chairman and CEO to Open NASDAQ Stock Market on October 2, 2007
Date:10/1/2007

In Honor of National Breast Cancer Awareness Month And to Launch a New

Business Dedicated to Mammography Comfort

BEDFORD, Mass., Oct. 1 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX), a leading provider of diagnostic imaging and state-of-the-art digital imaging systems directed towards women's health, today announced it will open the NASDAQ Stock Market tomorrow, October 2, 2007, in New York at 9:30AM ET in recognition of National Breast Cancer Awareness Month, commemorated annually on October 1st. The Company has been listed on NASDAQ for seventeen years. Chairman and CEO of Hologic, Jack Cumming, will preside over the NASDAQ opening bell ceremony at the NASDAQ Market Site, located at 4 Times Square, New York City.

"We are honored and proud to open the NASDAQ Stock Market and emphasize our commitment to advancing the fight against breast cancer and bringing hope to those affected by this deadly disease," said Cumming. "The breast cancer statistics are staggering. Breast cancer is the most frequently diagnosed cancer in women."

The American Cancer Society reports that over 240,000 new cases of breast cancer are diagnosed each year, one of eight women will get this deadly disease. More than 40,000 American women will die from breast cancer this year. "The good news," Cumming said "is that thanks to breast cancer screening programs and improvements in technology, death rates from breast cancer have steadily decreased in women since 1990."

One example of Hologic's commitment to women's health is the recently completed acquisition of BioLucent, the maker of MammoPad, a clinically proven radiolucent breast cushion. Hologic believes many women avoid or delay mammograms for fear of discomfort. The disposable MammoPad creates a cushion between the woman and the mammography system -- making the experience more comfortable and ultimately less stressful. In addition, Hologic believes with the use of the MammoPad, there is improved tissue acquisition, which may aid the technologist in improved patient positioning. Clinical studies show that three out of four women experience an average 50% decrease in discomfort with MammoPad. More than 12 million women have already benefited from MammoPad.

In honor of Breast Cancer Awareness, Hologic plans to include a starter case of MammoPads with all digital mammography systems shipped this month in the United States with the hope of introducing more clinicians, technologists and women to this most beneficial and very simple to use technology. Hologic intends to launch multiple programs over the next year to "spread the news" about MammoPad, with the hope of making it accessible to all women.

"The associates of Hologic share one goal," Cumming said. "That goal is to work together to advance technology for women's health. Early detection can significantly improve a woman's chance of surviving breast cancer and we remain passionately committed to improving women's healthcare by providing a comprehensive portfolio of tools and innovations to aid in early detection. It is our hope that increased awareness will encourage more women to include screening mammography as part of their routine medical care."

To view the opening of the NASDAQ Stock Market "live" on October 2, 2007, at 9:15AM ET, visit http://www.NASDAQ.com/reference/marketsite_about.stm. Scroll down to the bottom of the page to access the Market Site live web cam link. Windows media player is required to view the web cam.

About Hologic

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic and medical imaging systems dedicated to serving the healthcare needs of women, and a leading developer of innovative imaging technology for digital radiography and breast imaging. Hologic's core business units are focused on mammography and breast biopsy, osteoporosis assessment, and mini C-arm and extremity MRI imaging for orthopedic applications. For more information visit http://www.hologic.com.

Forward Looking Statement Disclaimer

This News Release contains forward-looking information that involves risks and uncertainties, including statements regarding Hologic's plans, objectives, expectations and intentions. Such statements include, without limitation, statements regarding the anticipated benefits of Hologic's acquisition of BioLucent and related plans. These forward-looking statements are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those anticipated. Risks and uncertainties that may cause these forward looking statements to vary materially from Hologic's expectations, include, among others: problems may arise with the ability of Hologic to successfully integrate the businesses of BioLucent, which may result in the combined company not operating as effectively and efficiently as expected; Hologic may not be able to achieve the expected synergies from the acquisition or it may take longer than expected to achieve those synergies; the acquisition may involve unexpected costs or unexpected liabilities, or the effects of purchase accounting may be different from Hologic's expectations; and the combined company may be adversely affected by future legislative, regulatory, or tax changes as well as other economic, business and/or competitive factors. Other factors that could adversely affect Hologic's business and prospects are described in Hologic's filings with the Securities and Exchange Commission. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Hologic's expectations or any change in events, conditions or circumstances on which any such statement is based.

Contact: Glenn P. Muir Frances Crecco

Executive Vice President & CFO Director, Investor Relations

Hologic, Inc. Hologic, Inc.

(781) 999-7300 (781) 999-7377


'/>"/>
SOURCE Hologic, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Psychological consequence of terrorist attacks
2. Breast Cancer Surgery Causes Psychological problems
3. Gastrointestinal Complaint to be dealt Psychologically
4. Prolonged survival not assured by psychological therapies for cancer patients
5. Pathological gambling is associated to brain functions
6. Is low birth weight related to psychological distress in adulthood?
7. Psychological Stress Delays Wound Healing
8. Wound healing affected by Psychological stress
9. Eating together has both psychological and health impacts
10. 9/11 Escapees Have Worsening Respiratory And Psychological Problems
11. Psychological effect on obese kids due to bullying
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... Hills, CA (PRWEB) , ... April 29, 2016 , ... ... of devices and products for the head and neck/ear, nose and throat specialty, has ... Device , The KOTLER NASAL AIRWAY™ is a newly patented safety device ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... growth round of funding led by Eastside Partners, with participation from existing investor ... growing customer base and accelerate its technology and product roadmap. , ...
(Date:4/29/2016)... ... April 29, 2016 , ... Regenerative Medicine Solutions (RMS) scored 94.8124 ... survey, earning them second place for Tampa’s Best Places to Work. They were ranked ... is a great accomplishment for our team,” says RMS Human Resources Manager Irene Miller. ...
(Date:4/29/2016)... ... April 29, 2016 , ... The infertility specialists at HRC Fertility/Orange County (HRC/OC) ... Daniel A. Potter -- are proud of the recent release of their 2014 in ... SART published the latest verified data for 375 U.S. member clinics. *Preliminary ...
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, Inc. recently sent representatives ... Petbiotics ™, as they fondly call them. As animal lovers, they were ... their non-profit organizations. Animal rescues across the nation face huge hurdles rescuing animals ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... Calif. , April 29, 2016  In ... is projected to shift from systems dependent on ... all types of modality CRT Medical monitors and ... there are a host of foreseeable benefits to ... concern; will existing modalities have to be replaced ...
(Date:4/29/2016)... 2016 ReportsnReports.com adds "Pulmonary ... research report that provides an overview of the ... various stages, therapeutics assessment by drug target, mechanism ... molecule type, along with latest updates, and featured ... players involved in the therapeutic development for Pulmonary ...
(Date:4/29/2016)... April 29, 2016 Acquisition ... Sciences, Product Development Capabilities in North ... Base . Indegene ( http://www.indegene.com ... the acquisition of Skura Corporation,s life science business. ... adaptive sales enablement technology for life science organizations ...
Breaking Medicine Technology: